PMC5701586_01
Pretreatment CT shows one target lesion measuring 87 mm in diameter and attenuation of 81 HU (arrow)
WO-21-30596-g001.jpg
PMC5701586_01_WO-21-30596-g001.jpg
f0001
Subsequently, based on CT scans, as well as a clinical evaluation the patient was qualified for transarterial chemoembolization (Fig. 1, 2).
CT scan after the last cycle of TACE showing decrease in diameter of the target lesion (60 mm) and a decrease in attenuation - 39 HU (arrow)
WO-21-30596-g002.jpg
PMC5701586_01_WO-21-30596-g002.jpg
f0002
Subsequently, based on CT scans, as well as a clinical evaluation the patient was qualified for transarterial chemoembolization (Fig. 1, 2).
Pretreatment angiogram shows diffuse pattern of contrast enhancement throughout liver without distinct nodules
WO-21-30596-g003.jpg
PMC5701586_01_WO-21-30596-g003.jpg
f0003
The angiographic image of metastases was diffuse infliltrative staining pattern without distinct nodularity (Fig. 3).